Harbour Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4,300
| Closed | -$538K | – | 249 |
|
|
2018
Q2 | $538K | Sell |
4,300
-300
| -7% | -$37.5K | 0.23% | 123 |
|
|
2018
Q1 | $513K | Buy |
4,600
+1,700
| +59% | +$190K | 0.22% | 134 |
|
|
2017
Q4 | $347K | Buy |
+2,900
| New | +$347K | 0.14% | 166 |
|
|
2017
Q2 | – | Sell |
-3,520
| Closed | -$427K | – | 621 |
|
|
2017
Q1 | $427K | Buy |
3,520
+1,075
| +44% | +$130K | 0.19% | 138 |
|
|
2016
Q4 | $299K | Hold |
2,445
| – | – | 0.21% | 138 |
|
|
2016
Q3 | $300K | Buy |
+2,445
| New | +$300K | 0.19% | 149 |
|